Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Dec 02, 2022 5:42pm
136 Views
Post# 35147811

RE:RE:Employer - Self Funded Plans

RE:RE:Employer - Self Funded Plans
molotov420 wrote: they should really spend more on marketing...last quarter seems like a record low of $51K spent compared to $228K in 2021. In the MD&A they say in 2022 they "Expanded marketing programs" and in the next 12 months they will be focusing on "Driving revenue growth by significantly increasing spend against promotion". That is the first item on the list!!! Can't say I'm thrilled when their LinkedIn is all I am seeing. Lets go SZLS, get your product out there beyond your 800 followers!


Companies selling a new backpack have a better marketing plan than this outfit.

I mean we should be seeing ads everywhere on facebook and other places that cost a pathetic small amount to do yet we see nothing. They could pay a co op student to do it.

Just another example of the joke that is StageHeadingToZero.

18 months after buying a company that made $1M a quarter this outfit can only muster $800K a quarter now.

WHAT PROGRESS!

<< Previous
Bullboard Posts
Next >>